Press Releases

OncoSec Announces $15 Million At Market Investment from Alpha Holdings, Inc.

Sep 04, 2018 7:30am EDT

OncoSec to Present at H.C. Wainwright 20th Annual Global Investment Conference

Aug 31, 2018 8:00am EDT

OncoSec Appoints Alain Algazi, MD, as Clinical Strategic Advisor

Aug 28, 2018 8:00am EDT

OncoSec Enters Research Collaboration Agreement with UCLA and Roger S. Lo, M.D., Ph.D.

Aug 06, 2018 8:00am EDT

OncoSec Appoints Robert W. Ashworth, Ph.D. as Vice President, Regulatory

Jul 30, 2018 8:00am EDT

OncoSec Presents Update from Triple Negative Breast Cancer Program at 3rd Global Insight Conference on Breast Cancer

Jul 17, 2018 8:00am EDT

OncoSec Appoints Sara M. Bonstein as Chief Financial Officer and Chief Operating Officer

Jul 16, 2018 8:00am EDT

OncoSec Provides Outlook for Second Half of 2018

Jun 28, 2018 8:00am EDT

OncoSec Added to the Russell Microcap® Index

Jun 25, 2018 8:00am EDT

OncoSec Presents Update on PISCES/KEYNOTE-695 Phase 2b Registration-Directed Clinical Trial in Combination with Merck's KEYTRUDA® for Metastatic Melanoma at the ASCO 2018 Annual Meeting

Jun 04, 2018 8:00am EDT